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Abstract. 
 
SR proteins are required for constitutive pre-
mRNA splicing and also regulate alternative splice site 
selection in a concentration-dependent manner. They 
have a modular structure that consists of one or two 
RNA-recognition motifs (RRMs) and a COOH-termi-
nal arginine/serine-rich domain (RS domain). We have 
analyzed the role of the individual domains of these 
closely related proteins in cellular distribution, subnu-
clear localization, and regulation of alternative splicing 
in vivo. We observed striking differences in the local-
ization signals present in several human SR proteins. In 
 
contrast to earlier studies of RS domains in the 
 
Droso-
phila
 
 suppressor-of-white-apricot (SWAP) and Trans-
former (Tra) alternative splicing factors, we found that 
the RS domain of SF2/ASF is neither necessary nor suf-
ficient for targeting to the nuclear speckles. Although 
this RS domain is a nuclear localization signal, subnu-
clear targeting to the speckles requires at least two of 
the three constituent domains of SF2/ASF, which con-
tain additive and redundant signals. In contrast, in two 
SR proteins that have a single RRM (SC35 and SRp20), 
the RS domain is both necessary and sufficient as a tar-
geting signal to the speckles. We also show that RRM2 
of SF2/ASF plays an important role in alternative splic-
ing specificity: deletion of this domain results in a pro-
tein that, although active in alternative splicing, has al-
tered specificity in 5
 
9
 
 splice site selection. These results 
demonstrate the modularity of SR proteins and the im-
portance of individual domains for their cellular local-
ization and alternative splicing function in vivo.
 
N
 
umerous
 
 protein and ribonucleoprotein compo-
nents are required to catalyze pre-mRNA splic-
ing, which occurs within a macromolecular com-
 
plex, the spliceosome. The major components of the
spliceosome, which assembles on individual pre-mRNAs,
are the small nuclear ribonucleoprotein particles (snRNPs)
 
1
 
U1, U2, and U4/6·U5; the polypeptides that associate with
hnRNA to form hnRNP particles (hnRNP proteins); and a
large set of non-snRNP protein splicing factors, which in-
cludes the SR family of proteins (for reviews see Dreyfuss
et al., 1993; Fu, 1995; Krämer, 1996; Manley and Tacke,
1996).
The SR proteins are essential splicing factors and also
regulate alternative splicing of many pre-mRNAs by af-
fecting the selection of 5
 
9
 
 splice sites (Ge and Manley,
1990; Krainer et al., 1990
 
a
 
,
 
b
 
; Zahler et al., 1993; for review
see Horowitz and Krainer, 1994). Their activity in alterna-
tive splicing is antagonized by members of the hnRNP A/
B family of proteins (Mayeda and Krainer, 1992; Mayeda
et al., 1994). Thus, the counteracting activities of these two
families of antagonistic factors can regulate alternative
splicing, both in vitro and in vivo (Mayeda and Krainer,
1992; Cáceres et al., 1994; Yang et al., 1994). SR proteins
are characterized by the presence of one or two copies of
the RNA-recognition motif (RRM) and a COOH-terminal
domain rich in arginine and serine residues (RS domain)
(Zahler et al., 1992; for review see Birney et al., 1993).
These proteins are thus very closely related in their do-
main structure, primary sequence, and functional proper-
ties. Individual SR proteins interact with pre-mRNA dur-
ing the early stages of spliceosome assembly (Krainer et
al., 1990
 
b
 
; Fu, 1993; Staknis and Reed, 1994; Zahler and
Roth, 1995) and stimulate binding of U1 snRNP particles
to the 5
 
9
 
 splice site (Eperon et al., 1993; Kohtz et al., 1994)
and binding of U2AF to the 3
 
9
 
 splice site (Zuo and Mania-
tis, 1996).
Splicing factors are distributed nonrandomly within the
nucleus. Immunofluorescence localization studies showed
that snRNP particles and SR proteins are organized in the
interphase nucleus in a characteristic speckled pattern.
Two morphologically distinct nuclear structures have been
identified as constituents of the nuclear speckles by elec-
tron microscopy: interchromatin granule clusters and peri-
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chromatin fibrils (for review see Spector, 1993). The
speckled pattern comprises 20–50 regions that are highly
concentrated in splicing factors (Spector, 1990; Huang and
Spector, 1992). Immunofluorescence staining and immu-
noelectron microscopy studies showed that the splicing
factor SC35, a member of the SR family of proteins, colo-
calizes with snRNPs within the nuclear speckle domains
(Fu and Maniatis, 1990; Spector et al., 1991). In some cell
types, snRNPs can be additionally found in another dis-
crete nuclear structure, the coiled body (for review see La-
mond and Carmo-Fonseca, 1993).
The nuclear organization of splicing factors is dynamic,
as shown by the fact that inhibition of transcriptional and/
or splicing activity causes reorganization of the nuclear
speckles (Spector et al., 1983; O’Keefe et al., 1994). The
most intense speckled regions are adjacent to, but not co-
incident with, transcriptionally active sites, as defined by
fluorescent labeling of nascent RNAs (Wansink et al.,
1993) and by in situ hybridization (Huang and Spector,
1991; Xing et al., 1993, 1995). Likewise, the interchromatin
granule clusters are not sites of tritiated uridine incorpora-
tion (for review see Fakan and Puvion, 1980). The fact that
splicing does not appear to take place at the majority of
sites where splicing factors are most concentrated (Mattaj,
1994; Zhang et al., 1994; Huang and Spector, 1996) led to
the suggestion that splicing factors shuttle between inter-
chromatin granule clusters (sites of storage and/or reas-
sembly) and perichromatin fibrils (sites of active transcrip-
tion and splicing) (Jiménez-García and Spector, 1993).
Many introns, though not all, are spliced as nascent tran-
scripts in vivo (Beyer and Osheim, 1988; Bauren and
Wieslander, 1994; Kiseleva et al., 1994). An intimate con-
nection between transcription and splicing is further sug-
gested by the observation that a subpopulation of hyper-
phosphorylated RNA polymerase II localizes to the nuclear
speckle domains (Bregman et al., 1995; Mortillaro et al.,
1996). The hyperphosphorylated COOH-terminal domain
of the polymerase large subunit appears to mediate inter-
actions with components related to splicing (Mortillaro et
al., 1996; Yuryev et al., 1996; Du and Warren, 1997; Mc-
Cracken et al., 1997).
Several protein kinases capable of phosphorylating SR
proteins on serine residues in vitro have been described:
SRPK1 (Gui et al., 1994
 
a
 
,
 
b
 
), Clk/Sty (Colwill et al., 1996),
a lamin-B receptor-associated kinase (Nikolakaki et al.,
1996), and unexpectedly, DNA topoisomerase I (Rossi et
al., 1996). In addition, it has been shown that addition of
SRPK1 to permeabilized cells (Gui et al., 1994
 
a
 
) or over-
expression of Clk/Sty (Colwill et al., 1996) results in a dif-
fuse distribution of splicing factors, probably because of
hyperphosphorylation of their RS domains. It has been
proposed that the level of phosphorylation may control
the subnuclear distribution of SR proteins in interphase
cells and the reorganization of the speckle domains during
mitosis (Colwill et al., 1996; Gui et al., 1994
 
a
 
; Misteli and
Spector, 1996).
Previous studies showed that the RS domains of two
 
Drosophila
 
 splicing regulators, suppressor-of-white-apri-
cot (SWAP) and Transformer (Tra), direct these splicing
factors to the nuclear speckles (Li and Bingham, 1991;
Hedley et al., 1995). We sought to investigate the role of
the structural domains of SR proteins in cellular and sub-
 
nuclear localization and to study the requirement for indi-
vidual domains of these proteins for modulation of alterna-
tive splicing in vivo. To this end, we transiently overexpressed
in HeLa cells several epitope-tagged SR protein cDNAs
encoding either the wild-type proteins or several mutant
derivatives thereof. We then determined the cellular dis-
tribution of the tagged proteins, as well as their activity in
regulating alternative splicing of transcripts expressed from
cotransfected reporter genes. We found that SR proteins
that have either one or two RRMs differ in their require-
ments for the RS domain as a nuclear speckle targeting
signal. We also demonstrate that the presence of RRM2
can affect the alternative splicing specificity of SF2/ASF in
vivo, suggesting that the modular structure of SR proteins
is important for regulated splicing.
 
Materials and Methods
 
Epitope-tagged Expression Plasmids
 
Oligonucleotide primers were purchased from GIBCO BRL (Gaithers-
burg, MD). PCR conditions using Vent polymerase (New England Bio-
labs, Beverly, MA) were as previously described (Krainer et al., 1991).
The epitope-tagged, full-length SF2/ASF expression plasmid was con-
structed by amplifying an SF2/ASF cDNA (Krainer et al., 1991) with spe-
cific primers and subcloning of the resulting PCR product as an XbaI-
BamHI fragment into the pCGTHCF
 
FL
 
T7 expression vector (Wilson et
al., 1995). The resulting vector, pCGT7-SF2, like the previously described
pCG-SF2 vector, is under the control of the cytomegalovirus enhancer/
promoter (Tanaka and Herr, 1990; Cáceres et al., 1994) but also includes
an NH
 
2
 
-terminal epitope tag, MASMTGGQQMG. This epitope tag cor-
responds to the first 11 residues of the bacteriophage T7 gene 10 capsid
protein and is recognized by the T7 tag monoclonal antibody (Novagen,
Inc., Madison, WI). The SF2/ASF mutants and domain deletions were
previously described (Cáceres and Krainer, 1993) and were subcloned
into the same epitope-tagged expression vector as wild-type SF2/ASF. For
the SRp40, SC35, SRp20, and hnRNP A1 constructs, PCR products were
amplified with specific primers and subcloned into the same expression
vector. In the case of the SRp20 constructs, because of the presence of an
internal XbaI site in the SRp20 cDNA, the amplified fragments were de-
signed with SpeI and BamHI sites and were subcloned into the XbaI-
BamHI sites of pCGT7-SF2. In the case of the SRp40 constructs, because
of the presence of an internal BamHI site in the SRp40 cDNA, the ampli-
fied fragments were designed with XbaI and BclI sites and were subcloned
into the XbaI-BamHI sites of pCGT7-SF2. The SRp40-
 
D
 
RS protein com-
prises residues 2–183; SC35-
 
D
 
RS comprises residues 2–94; and SRp20-
 
D
 
RS comprises residues 2–85. Construction of the A1-RS protein was pre-
viously described (Mayeda et al., 1994); this chimeric protein comprises
amino acids 1–185 from hnRNP A1 and 195–248 from SF2/ASF.
For the nucleoplasmin fusions, the vector pCGT7-NPc was constructed
by amplifying a 
 
Xenopus
 
 nucleoplasmin cDNA (Dingwall et al., 1987)
with specific primers and cloning the resulting PCR product into the XbaI
and BamHI sites of the pCGTHCF
 
FL
 
T7 expression vector. This procedure
results in the insertion of amino acids 2–149 of nucleoplasmin followed by
an XbaI site and stop codon, COOH-terminal to the T7 epitope. This nu-
cleoplasmin fragment is also known as the nucleoplasmin core domain,
NPc. PCR fragments comprising residues 198–248 from the RS domain of
SF2/ASF or 88–164 from the RS domain of SRp20 were subcloned down-
stream of NPc to generate NPc-RS
 
SF2
 
 and NPc-RS
 
SRp20
 
, respectively.
 
Cell Culture and Transfections
 
HeLa cells were grown in DME supplemented with 10% FCS and trans-
fected with 1 
 
m
 
g of plasmid DNA per 60-mm dish of 60–75% confluent
cells, in the presence of 20 
 
m
 
g lipofectin (GIBCO BRL) (Cáceres et al.,
1994).
 
Indirect Immunofluorescence
 
Cells were fixed for immunofluorescence assays 24 h after transfection.
Cells were washed with PBS and incubated with 3% paraformaldehyde, 
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0.3% Triton (in PBS) for 5 min at room temperature, followed by incuba-
tion with 3% paraformaldehyde for 30 min. The fixed cells were incubated
for 1 h at room temperature with 1:500 anti-T7 monoclonal antibody
(Novagen, Inc.). The cells were washed three times with PBS and incu-
bated for 1 h at room temperature with 1:500 fluorescein-conjugated goat
anti–mouse IgG (Cappel Laboratories, Malvern, PA). Double immuno-
fluorescence labeling was performed by incubation for 1 h at room tem-
perature with 1:500 anti-T7 monoclonal antibody (Novagen, Inc.) and 1:
2,000 human anti-Sm serum. After washing, the cells were incubated with
1:50 Texas red–conjugated antimouse IgG and 1:50 fluorescein-conju-
gated antihuman IgG (Cappel Laboratories). Samples were observed on a
microscope (model Axiovert 405M; Carl Zeiss, Inc., Thornwood, NY),
and images were acquired with a cooled CCD camera (model NU200;
Photometrics, Inc., Woburn, MA) using Oncor Image software (Gaithers-
burg, MD). For confocal microscopy, a confocal laser scanning micro-
scope (model LSM410; Carl Zeiss, Inc.) was used. For localization of the
endogenous SF2/ASF protein, a monoclonal antibody against SF2/ASF
was used as culture supernatant at a 1:5 dilution.
 
Quantitation of Fluorescence Images
 
Images were acquired under identical conditions, ensuring that the maxi-
mal signal was not saturating, and were subjected to contrast stretching,
excluding the top and bottom 1% of pixels. Acquisition of images and
measurements were performed using Oncor Image software 2.0.04. To
measure the intensity of speckles, a modified version of a point-hit
method was used (Weibel et al., 1969). Random test lines were drawn
over the cell nucleus, several pairs of random test points on the test line
were chosen arbitrarily, and the absolute intensity value of the test points
was measured (
 
X
 
1
 
, 
 
X
 
2
 
). A value 
 
S
 
 for the intensity of speckles was deter-
mined as the ratio between the sum of differences and the average inten-
sity value of all points on the test line (
 
X
 
av
 
):
 
N
 
 represents the number of pairs of test points used for one sample. Typi-
cally, four to six pairs of test points were chosen arbitrarily on a test line,
and a minimum of three test lines were used for every cell nucleus exam-
ined. For each sample, at least four nuclei were examined. All results rep-
resent values obtained from two separate experiments, and the results are
average values 
 
6
 
 standard deviation from the pooled data.
 
In Vivo Analysis of Alternative Splicing
 
Transfections of HeLa cells and purification of total RNA were as previ-
ously described (Cáceres et al., 1994). Briefly, 1 
 
m
 
g of expression plasmid
was cotransfected into HeLa cells with 6 
 
m
 
g of the adenovirus E1A re-
porter plasmid pMTE1A (Zerler et al., 1986) in the presence of 20 
 
m
 
g of
Lipofectin (GIBCO BRL). The cells were grown to 60–75% confluence in
60-mm dishes and harvested 24 or 48 h after transfection, and 200 ng of to-
tal RNA was analyzed by reverse transcriptase PCR (RT-PCR), as de-
scribed (Screaton et al., 1995). Briefly, first-strand oligo(dT)-primed
cDNA synthesized with superscript II (GIBCO BRL) from 200 ng of total
RNA was amplified with Taq DNA polymerase (Perkin-Elmer Corp.,
Norwalk, CT) for 25 cycles, using 5
 
9
 
-end–labeled forward primer. Ampli-
fied products separated by urea-PAGE were detected by autoradiography
and quantitated by PhosphorImage analysis (Fujix, BAS2000; Fuji Photo
Film Co., Tokyo, Japan). The PCR primers were previously described
(Cáceres et al., 1994).
 
Results
 
Role of the Structural Domains of SR Proteins in 
Cellular Distribution and Subnuclear Localization
 
First, we analyzed the localization of the endogenous SF2/
ASF protein using an anti-SF2/ASF monoclonal antibody
(Krainer, A.R., unpublished). This antibody does not cross-
react with other SR proteins and detects all phosphoryla-
tion variants of SF2/ASF; its detailed characterization will
be published elsewhere. We observed a typical nuclear
speckled pattern and also a diffuse nuclear signal, but no
S
S X2 X1 Xav ¤ – ()
N
------------------------------------------ . =
 
nucleolar staining (Fig. 1). This immunofluorescence pat-
tern resembles that of endogenous U2B
 
99
 
 and Sm snRNP
proteins (for review see Spector, 1993). No staining of
coiled bodies was observed, in agreement with previous
data on SC35 localization (Spector et al., 1991).
To determine the role of individual domains of SF2/ASF
and other SR proteins in nuclear and subnuclear localiza-
tion, we transiently overexpressed in HeLa cells several
epitope-tagged SR protein cDNAs encoding either the
wild-type proteins or several mutant derivatives and deter-
mined the cellular distribution and subnuclear localization
of the tagged proteins by indirect immunofluorescence mi-
croscopy. We verified the expression of all the transfected
cDNAs by Western blot analysis of whole-cell lysates. All
constructs encoded proteins with a bacteriophage T7 gene
10 (T7) epitope tag at their NH
 
2
 
 termini (see Materials
and Methods), allowing detection of the exogenous pro-
teins with a monoclonal antibody that recognizes this
epitope. All expressed proteins accumulated to similar lev-
els in transfected HeLa cells and appeared to be full
length; in most cases, doublets were detected, which may
represent different states of phosphorylation (data not
Figure 1. Localization of endogenous SF2/ASF. HeLa cells were
fixed, and the cellular localization of SF2/ASF was determined by
indirect immunofluorescence with an anti-SF2/ASF monoclonal
antibody (Krainer, A.R., unpublished). The protein localizes in a
speckled nuclear pattern and is also diffusely distributed through-
out the nucleoplasm. (Top) DIC image; (bottom) fluorescence
image of the same field. Bar, 10 mm. 
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shown). In the case of SF2/ASF wild-type and mutant pro-
teins, the use of an anti-SF2/ASF monoclonal antibody al-
lowed us to compare the levels of exogenous and endoge-
nous SF2/ASF in the cell population. After normalizing
for transfection efficiency, we estimate that the transiently
expressed proteins accumulate in the transfected cells at
5–10-fold higher levels than endogenous SF2/ASF, which
is in good agreement with our previous results (Cáceres et
al., 1994; and data not shown).
Indirect immunofluorescence using the T7 tag antibody
showed that 24 h after transfection, the transiently ex-
pressed wild-type SF2/ASF protein localized exclusively in
the nucleus, with a typical speckled pattern (Fig. 2 
 
a
 
). 48 h
after transfection, SF2/ASF overexpression resulted in the
formation of nuclear aggregates: the speckles were fewer
in number and appeared enlarged (data not shown), in
agreement with previous reports (Hedley et al., 1995; Ro-
mac and Keene, 1995). The remaining localization data
were obtained at the shorter time point, when the nuclear
staining pattern of the transiently expressed wild-type pro-
tein coincides with that of the endogenous protein in un-
treated cells. This concordance suggests that transient ex-
pression is a valid approach to study the localization
signals of SR proteins. Although the transfected proteins
are expressed at higher levels, we note that the natural
abundance of individual SR proteins fluctuates consider-
ably in different cell types and that modulation of the lev-
els of these proteins appears to be the key to their role in
alternative splicing (Ge and Manley, 1990; Krainer et al.,
1990
 
a
 
; Zahler et al., 1993; Cáceres et al., 1994).
The localization of several transiently expressed SF2/
ASF domain-deletion mutants was then compared to that
of the wild-type protein (SF2-WT). The structures of the
mutant proteins, designated 
 
D
 
RS, RRM1/RS, RRM2/RS,
RRM1, and RRM2, have been previously described
(Cáceres and Krainer, 1993). (RRM2 has sometimes been
Figure 2. Role of SF2/ASF
structural domains in cellular
localization and distribution
in the nuclear speckles. The
structure of the SF2/ASF do-
main-deletion mutants was
previously described (Cá-
ceres and Krainer, 1993). (a)
SF2-WT, (b) SF2-DRS, (c)
RRM1/RS, (d) RRM2/RS,
(e) RRM1, (f) RRM2. HeLa
cells were transfected with
plasmids encoding the re-
spective T7-tagged proteins
and fixed 24 h after transfec-
tion. The localization of the
expressed proteins was de-
termined by indirect immuno-
fluorescence with anti-T7
monoclonal antibody and
FITC-conjugated secondary
antibody. Bar, 5 mm. 
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referred to as pseudo-RRM, 
 
C
 
RRM, or RRM-homology,
because of its lack of canonical RNP-1 and RNP-2 submo-
tifs; see Birney et al., 1993.) In contrast to wild-type SF2/
ASF, the 
 
D
 
RS mutant protein localized mostly in the nu-
cleus (excluding the nucleoli) but also in the cytoplasm;
unexpectedly, nuclear speckles were still clearly detectable
(Fig. 2 
 
b
 
). This observation demonstrates that the RS do-
main of SF2/ASF, although required for exclusive nuclear
localization, is not essential for subnuclear localization to
the speckles. The RRM1/RS and RRM2/RS mutant pro-
teins displayed a similar cellular distribution to that ob-
served with the 
 
D
 
RS mutant protein, and they also local-
ized to speckles (Fig. 2, 
 
c
 
 and 
 
d
 
). In contrast, when
individual domains were expressed (RRM1 or RRM2),
the mutant proteins localized throughout the cell, and no
nuclear speckles were detected (Fig. 2, 
 
e
 
 and 
 
f
 
). Expres-
sion of just the epitope-tagged RS domain from SF2/ASF
was very inefficient and could not be detected by immuno-
fluorescence (data not shown).
The transiently expressed SF2-WT and SF2-
 
D
 
RS pro-
teins colocalized with snRNP particles in the endogenous
speckles, as shown by confocal laser scanning microscopy
using the anti–T7 tag mouse monoclonal antibody (red)
(Fig. 3, 
 
a
 
 and 
 
d
 
) and a human autoimmune serum specific
for the Sm core proteins of snRNP particles (green) (Fig.
3, 
 
b
 
 and 
 
e
 
). Colocalization of SF2/ASF proteins and sn-
RNPs results in a yellow color (Fig. 3, 
 
c
 
 and 
 
f
 
). We con-
clude that transiently expressed SF2-WT and a fraction of
SF2-
 
D
 
RS proteins localize properly to nuclear speckles
containing endogenous snRNPs.
These experiments demonstrate that all three structural
domains of SF2/ASF are required for exclusive nuclear lo-
calization since deletion of the RS domain, or of either
RRM, resulted in proteins with both nuclear and cytoplas-
mic distribution. However, there appears to be functional
redundancy in the speckle localization signals within SF2/
ASF. At least two domains are necessary for SF2/ASF lo-
calization to nuclear speckles: either two copies of the
RRM or one of the two RRMs together with the RS do-
main.
Next, we analyzed the effect of deleting the RS domain
from another SR protein that has two RRMs (SRp40), and
from two SR proteins that have a single RRM (SC35 and
SRp20). To this end, these epitope-tagged proteins (either
wild-type proteins or mutant proteins lacking the RS do-
main) were transiently expressed in HeLa cells, and their
cellular localization was analyzed by indirect immunofluo-
rescence. Wild-type SRp40 localized exclusively to the nu-
cleus and showed a typical speckled pattern (Fig. 4 
 
a
 
). De-
letion of its RS domain resulted in localization both in the
nucleus (excluding the nucleoli) and in the cytoplasm;
however, nuclear speckles were clearly detected (Fig. 4 
 
b
 
),
as was the case with SF2/ASF lacking its RS domain. Both
SC35 and SRp20 wild-type proteins also localized exclu-
Figure 3. Colocalization of transiently expressed SF2/ASF, with or without its RS domain, with endogenous snRNPs. HeLa cells were
transiently transfected with plasmids expressing T7-tagged, wild-type SF2/ASF (SF2-WT; top row) or a derivative lacking the RS do-
main (SF2-DRS; bottom row). The cells were fixed 24 h after transfection and analyzed by double-label immunofluorescence using laser
scanning confocal microscopy. SF2/ASF or SF2-DRS were detected using an anti-T7 mouse monoclonal antibody followed by Texas
red–conjugated secondary antibody (a and d). Endogenous snRNPs were detected in the same cell using an anti-Sm human serum fol-
lowed by FITC-conjugated secondary antibody (b and e). Both SF2-WT and SF2-DRS colocalized with endogenous snRNPs in nuclear
speckles, as shown by the yellow color when the two signals were superimposed (c and f). Bar, 5 mm. 
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sively to the nucleus and displayed a typical nuclear speck-
led pattern (Fig. 4, 
 
c
 
 and 
 
e
 
, respectively). In contrast,
SC35
 
D
 
RS and SRp20
 
D
 
RS localized throughout the cyto-
plasm and nucleoplasm, and no nuclear speckles were de-
tected (Fig. 4, 
 
d
 
 and 
 
f
 
); this cellular distribution is very similar
to that observed with the RRM1 and RRM2 single-domain
mutants of SF2/ASF (Fig. 2). These observations indicate
a significant difference in the localization signals present
in two SR proteins that have two copies of the RRM (SF2/
ASF and SRp40), and two SR proteins that have only one
RRM (SC35 and SRp20), since only in the latter case is the
RS domain absolutely required for localization to the speckle
domains. Quantitation of the fluorescence signals con-
firmed these qualitative observations. The relative inten-
sity of nuclear speckles was reduced by 30% in constructs
lacking one of the three domains and further reduced by
80% in those constructs lacking two domains. Loss of one
domain from two-domain SR proteins had the same effect
as loss of two domains from a three-domain SR protein.
The relative intensity values were similar for wild-type
SRp40, SC35, and SRp20 as compared to SF2/ASF, and
were similarly decreased for SC35-
 
D
 
RS and for SRp20-
 
D
 
RS, as compared to SF2/ASF RRM1 or RRM2 mutants
(Fig. 5).
The finding that the RS domain of SF2/ASF is not re-
quired for speckle localization was unexpected since previ-
ous work showed that the RS domains of 
 
Drosophila
 
 Tra
and SWAP (which have no RRMs) are necessary and suf-
ficient for targeting to speckles (Li and Bingham, 1991;
Hedley et al., 1995).
Although the RS domain of SF2/ASF is not required to
target SF2/ASF to the speckles, we tested whether it can
target a different protein to this subnuclear domain. We
assayed the subnuclear localization of a chimeric protein,
Figure 4. Cellular localiza-
tion of other transiently ex-
pressed SR proteins with or
without their RS domains.
HeLa cells were transfected
with plasmids encoding the
following epitope-tagged
proteins: (a) wild-type SRp40,
(b) SRp40-DRS, (c) wild-
type SC35, (d) SC35-DRS,
(e) wild-type SRp20, and (f)
SRp20-DRS. The cells were
fixed 24 h after transfection
and the localization of the ex-
pressed proteins was deter-
mined as in Fig. 1. Bar, 5 mm.Cáceres et al. Modularity of SR Proteins: Localization and Splicing 231
A1-RS, which consists of both RRMs from hnRNP A1 and
the RS domain from SF2/ASF replacing the natural
COOH-terminal glycine-rich domain (G-domain) of hnRNP
A1 (Mayeda et al., 1994). This domain of hnRNP A1 con-
tains a short signal for bidirectional transport between the
nucleus and the cytoplasm (Michael et al., 1995; Siomi and
Dreyfuss, 1995; Weighardt et al., 1995). The hnRNP A1
wild-type protein gave a diffuse nucleoplasmic staining
rather than a speckled pattern (Fig. 6 A, a), in agreement
with published data (for review see Piñol-Roma and Drey-
fuss, 1993). Replacing the G-domain of hnRNP A1 by the
RS domain of SF2/ASF did not target the chimeric protein
to the nuclear speckles (Fig. 6 A, b), demonstrating that, at
least in this context, the RS domain of SF2/ASF is not suf-
ficient to direct a heterologous protein to the nuclear
speckles. On the other hand, the A1-RS protein localized
exclusively in the nucleus, whereas hnRNP A1 lacking a
COOH-terminal domain is known to localize throughout
the cell (Siomi and Dreyfuss, 1995). Therefore, the RS do-
main of SF2/ASF is a nuclear localization signal, but not a
subnuclear speckle localization signal.
Next, we compared the nuclear localization signals as
well as the subnuclear targeting properties of both types of
RS domain, i.e., those present in SR proteins with either
one or two copies of the RRM. To this end, we con-
structed chimeric proteins in which the RS domain of ei-
ther SF2/ASF or SRp20 was fused to a protein reporter,
the nucleoplasmin core domain. This protein fragment by
itself displays a cytoplasmic distribution (Fig. 6 B, a) since
it lacks the nuclear localization signal present in wild-type
nucleoplasmin (Dingwall et al., 1987). Both types of RS
domain act as nuclear localization signals, as demonstrated
by the fact that both NPc-RSSF2 and NPc-RSSRp20 localized
to the nucleus (Fig. 6 B, b and c). However, a clear differ-
ence was evident in the ability of these RS domains to tar-
get a protein reporter to the nuclear speckles. Whereas a
diffuse nuclear staining was observed with the SF2/ASF
RS domain (Fig. 6 B, b), the RS domain of SRp20 was suf-
ficient to direct the NPc reporter to the nuclear speckles
(Fig. 6 B, c). The nuclear speckles observed with the NPc
reporter fused to the RS domain of SRp20 colocalized
with endogenous human Sm (Fig. 6 C), as shown by confo-
cal laser microscopy using the mouse anti–T7 tag mono-
clonal antibody (red) (Fig. 6 C, a) and human autoimmune
serum specific for the Sm core proteins of snRNP particles
(green) (Fig. 6 C, b). Colocalization of NPc-RSSRp20 pro-
tein and snRNPs results in a yellow color (Fig. 6 C, c). We
conclude that the transiently expressed NPc-RSSRp20 pro-
tein localizes properly in nuclear speckles containing en-
dogenous snRNPs, demonstrating that this RS domain is
sufficient to determine subnuclear localization in the
speckle domain. These experiments demonstrate the exist-
ence of two distinct pathways for localization of different
SR proteins to the nuclear speckles and also show the
unique properties of individual RS domains.
Role of SF2/ASF Domains in Alternative Splicing 
Regulation In Vivo
In addition to their function as general splicing factors, SR
proteins regulate alternative splicing in a concentration-
dependent manner (Ge and Manley, 1990; Krainer et al.,
1990a; Zahler et al., 1993). We sought to investigate the
role of individual domains of SF2/ASF in the regulation of
alternative splicing in vivo. To this end, we overexpressed
several of the constructs described above and assayed
changes in the patterns of alternative splicing of an adeno-
virus E1A splicing reporter. It was previously shown that
SF2/ASF strongly activates the use of the proximal 13S
E1A 59 splice site in vivo (Cáceres et al., 1994; Wang and
Manley, 1995) and that overexpression of hnRNP A1 re-
sults in activation of the distal 9S 59 splice site (Cáceres et
al., 1994; Yang et al., 1994). Compared to wild-type SF2/
ASF, which gave the expected activation of the 13S 5 9
splice site (Fig. 7 B, lane 2), the DRS protein led to only
slightly lower relative levels of 13S mRNA (Fig. 7 B, lane
3), demonstrating that the RS domain of SF2/ASF is not
required for alternative splicing modulation in vivo. This
result is consistent with previous findings (Wang and Man-
ley, 1995), except that in the earlier study the 9S mRNA
levels remained constant for both wild-type and DRS pro-
teins, whereas in our hands they decreased, as expected
from in vitro studies. The SF2/ASF mutants with a single
RRM and the RS domain had strikingly different func-
tional properties: both proteins influenced alternative
splicing, but whereas RRM2/RS strongly activated the 13S
59 splice site (Fig. 7 B, lane 5), RRM1/RS strongly and re-
producibly stimulated the 12S 59 splice site (Fig. 7 B, lane
4). The unexpected altered specificity observed upon dele-
tion of RRM2 demonstrates that the nature of the RRM
can influence the selection of a particular 59 splice site. Ac-
tivation of the E1A 12S 59 splice site by the RRM1/RS mu-
tant is similar to the effect of SRp20, which naturally lacks
RRM2 (Fig. 7 B, lane 6; Screaton et al., 1995). Quantitation
Figure 5. Quantitative analysis of localization of transfected pro-
teins in nuclear speckles. The relative fluorescence intensity was
calculated as described in Materials and Methods. Note that the
relative intensity of speckles decreased by z30% for SF2/ASF
lacking one of its three domains, and by z80% when two of the
three domains were missing. Results represent average values 6
standard deviation from the pooled data of at least two experi-
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of the relative use of the E1A 59 splice sites upon overex-
pression of the different proteins is shown in Fig. 7 C.
Both constructs with a single RRM and the RS domain
(RRM1/RS and RRM2/RS) were also active in regulating
alternative splicing of a b-thalassemia splicing reporter,
leading in both cases to activation of the most proximal
cryptic 59 splice site (data not shown); this is a similar pat-
tern as that obtained with wild-type SF2/ASF (Cáceres et
al., 1994). We and others previously reported that deletion
of RRM1 or RRM2 in SF2/ASF abolished the alternative
splicing activity of this protein in vitro (Cáceres and
Krainer, 1993; Zuo and Manley, 1993). This apparent dis-
crepancy with our present results may reflect incorrect
folding of the mutant proteins in vitro, but not in vivo,
and/or the different pre-mRNA substrates used in the two
types of assays. Wang and Manley (1995) reported that
small deletions within RRM2 inactivated the protein in
vivo; since we find that deletion of the entire domain im-
parts a novel specificity on the protein in a similar assay, it
is likely that the small deletions disrupted the folding of
the RRM, which has a highly conserved tertiary structure
(for review see Birney et al., 1993).
Taken together, the cotransfection results suggest that
RRM2 of SF2/ASF plays a critical role in the specificity of
alternative splicing with certain substrates, such as the
E1A pre-mRNA. Thus, all the functional SR protein con-
structs that include RRM2 (SF2/ASF WT, DRS, and
RRM2/RS) favored the 13S 59 splice site, whereas those
that lack a second RRM (RRM1/RS and SRp20) selected
the 12S 59 splice site (Fig. 8). We conclude that there is a
different functional requirement for individual domains of
SR proteins in the regulation of alternative splicing in liv-
ing cells. Whereas the RS domain is dispensable for this
activity, as was previously demonstrated in vitro (Cáceres
and Krainer, 1993; Zuo and Manley, 1993), the presence of
a particular RRM can promote selection of a specific
splice site and also influence substrate specificity.
Discussion
We have studied the role of individual domains of SR pro-
teins in cellular distribution and subnuclear localization, as
well as in alternative splicing activity in vivo. Unexpected
differences were uncovered in the localization pathways
for different SR proteins, despite the close conservation of
structure and biochemical properties among members of
this protein family. SR proteins with a single RRM require
an RS domain for proper localization in the nuclear speck-
Figure 6. Cellular localiza-
tion of transiently expressed
chimeric proteins. HeLa cells
were transfected with plas-
mids encoding the following
epitope-tagged proteins: (A)
(a) hnRNP A1; (b) A1-RS, a
chimeric protein with both
RRMs from hnRNP A1
fused to the COOH-termi-
nal RS domain of SF2/ASF.
(B) (a) NPc, the nucleoplas-
min core domain; (b) NPc-
RSSF2, a chimera consisting
of NPc fused to the RS do-
main from SF2/ASF; (c)
NPc-RSSRp20, NPc fused to
the RS domain of SRp20.
The cells were fixed 24 h af-
ter transfection and the local-
ization of the expressed pro-
teins was determined as in
Fig. 1. (C) Colocalization of
transiently expressed NPc-
RSSRp20 with endogenous sn-
RNPs. HeLa cells were tran-
siently transfected with plas-
mid expressing T7-tagged
NPc-RSSRp20. The cells were
fixed 24 h after transfection
and analyzed by double-label
immunofluorescence using
confocal laser scanning mi-
croscopy. NPc-RSSRp20 was
detected using an anti-T7
mouse monoclonal antibody followed by Texas red–conjugated secondary antibody (a). Endogenous snRNPs were detected in the same
cell using an anti-Sm human serum followed by FITC-conjugated secondary antibody (b). NPc-RSSRp20 colocalized with endogenous sn-
RNPs in nuclear speckles, as shown by the yellow color when the two signals were superimposed (c). Bar, 5 mm.Cáceres et al. Modularity of SR Proteins: Localization and Splicing 233
les, whereas SR proteins with two RRMs do not; in the lat-
ter, weak speckle targeting signals are present in each of
the three constituent domains and function additively. The
fact that single-domain deletion variants of SF2/ASF local-
ized properly made it possible to determine the role of
each domain in alternative splicing in vivo. Each of the
three domains could be deleted individually without abro-
gating the ability of SF2/ASF to modulate alternative
splice site selection. Remarkably, however, deletion of
RRM2 imparted a distinct activity on the protein, such
that it promoted the selection of a different alternative 59
splice site in the adenovirus E1A pre-mRNA.
Nuclear Localization of SR Proteins
The SR protein SF2/ASF has a modular structure, consist-
ing of two RRMs and a COOH-terminal RS domain. Here
we showed that each of these three domains contributes
additively to the nuclear localization of the protein since
deletion of individual domains results in proteins that, un-
like the wild-type protein, no longer have an exclusively
nuclear distribution (Fig. 9). In particular, the RS domain
of SF2/ASF contributes to its nuclear localization since de-
letion of this domain causes nuclear and cytoplasmic dis-
tribution of the resulting mutant protein. In agreement
with this finding, when the RS domain of SF2/ASF was
fused to the NPc protein reporter (which on its own local-
izes in the cytoplasm), the fusion protein (NPc-RSSF2) lo-
calized in the nucleus (Table I). Thus, the SF2/ASF RS do-
main is a nuclear targeting signal.
We do not know at present whether the nuclear and cy-
toplasmic distribution observed with several mutants rep-
resents incomplete nuclear import and/or incomplete re-
tention of these proteins in the nucleus. Two alternative
explanations, which are not mutually exclusive, can be
proposed on the basis of our findings. In the first model,
there are multiple nuclear localization signals distributed
throughout SF2/ASF. These signals have additive effects,
such that deletion of either RRM, or of the RS domain, re-
duces the overall steady-state accumulation in the nucleus.
Thus, when all three structural domains are present, the
protein has an exclusively nuclear distribution. When only
two of the three domains are present, a fraction of the pro-
tein accumulates in the cytoplasm, and when only one do-
main is present, the proportion of cytoplasmic protein
greatly increases. In the second model, partition between
the nucleus and the cytoplasm can be attributed to incom-
plete nuclear retention of SF2/ASF mutants lacking either
RRM repeat or the RS domain. In support of this model,
we have shown that fusing the RS domain to a cytoplasmic
reporter, NPc, directs the fusion protein exclusively to the
nucleus. NPc is thought to have a propensity to be retained
in the nucleus, once it gets there, because of oligomeriza-
tion (Michael et al., 1995). In contrast, the SF2/ASF mu-
tant proteins that lack one of the two RRMs (RRM1/RS,
RRM2/RS) display mostly nuclear but also cytoplasmic lo-
Figure 7. Role of SF2/ASF
structural domains in regu-
lating alternative splicing of
adenovirus E1A pre-mRNA.
(A) Diagram of the E1A re-
porter gene. The alternative
59 splice sites and splicing
events that generate 13S,
12S, and 9S mRNAs are
shown schematically. The lo-
cation of the exon primers
used for RT-PCR analysis is
shown. (B) Alternative splic-
ing activity of the SF2/ASF
domain-deletion mutants.
Each of the indicated SF2/
ASF mutant and control pro-
teins was overexpressed from
plasmids cotransfected with
the E1A reporter gene. RNA
was harvested 24 h after
transfection and analyzed by
RT-PCR with a labeled for-
ward primer, denaturing
PAGE, and autoradiogra-
phy, as described in Materi-
als and Methods. The posi-
tions of the unspliced pre-
mRNA, and of 13S, 12S, and
9S spliced mRNAs are indi-
cated on the right. The back-
ground products obtained from mock-transfected cells are shown in lane 7. End-labeled DNA size markers are shown in lane M. (C)
Quantitation of E1A mRNA isoforms in transfected cells. The relative amounts of 13S, 12S, and 9S E1A mRNAs were calculated from
the data in B, using a PhosphorImager, and the percentage of each isoform is shown.The Journal of Cell Biology, Volume 138, 1997 234
calization, and they have been shown to have reduced
RNA binding, compared to the wild-type protein. SF2/ASF
RRM domains expressed individually distribute evenly
throughout the whole cell (Fig. 2) and bind RNA very
poorly (Cáceres and Krainer, 1993; Zuo and Manley, 1993).
In the case of SR proteins that in their natural form have
a single RRM (e.g., SC35 and SRp20), deletion of the RS
domain resulted in mutant proteins with nuclear and cyto-
plasmic distribution (Fig. 9). Therefore, the nuclear local-
ization mechanism appears to be different for the two SR
protein subfamilies: in the case of SC35 and SRp20, a sin-
gle RRM together with the RS domain resulted in exclusive
nuclear localization. In contrast, in the case of SF2/ASF,
either RRM together with the RS domain resulted in nuclear
and cytoplasmic distribution (RRM1/RS and RRM2/RS; Fig.
2), and exclusive nuclear localization was only achieved
when both RRMs were present together with the RS do-
main.
Localization of SR Proteins to Nuclear Speckles
The process of nucleo-cytoplasmic transport has been ex-
tensively studied, and several components of this pathway
have been identified (for reviews see Silver, 1991; Ding-
wall and Laskey, 1991; Görlich and Mattaj, 1996). In con-
trast, the mechanisms involved in localization of proteins
within specific subnuclear regions are poorly understood.
They may involve active transport mediated by subnuclear
targeting signals, or alternatively, passive diffusion and
binding to the nuclear matrix or its components. It has
been proposed that the speckle domains are anchored di-
rectly or indirectly to the nuclear matrix (Spector et al.,
1983). In agreement with this hypothesis, a role for the nu-
clear matrix in splicing has been postulated (Zeitlin et al.,
1987), and antibodies raised against components of the nu-
clear matrix cross-react with SR proteins (Blencowe et al.,
1994, 1995).
The RS domain is the most prominent feature shared by
splicing factors that localize in a speckled pattern. As such,
it is the best candidate domain to mediate this subnuclear
localization, as first proposed and tested with Drosophila
proteins by Bingham and coworkers (Li and Bingham,
1991). In the case of human SF2/ASF, we have shown that
the RS domain is neither necessary nor sufficient for local-
ization to the speckles. In marked contrast, deleting the
RS domain of two human SR proteins that have a single
RRM caused the mutant proteins to distribute throughout
the cell, and accumulation in the speckled region was no
longer observed. A similar result was obtained when ex-
pressing individual domains of SF2/ASF (RRM1 and RRM2
proteins). In addition, by fusing the RS domain of SRp20
to a cytoplasmic protein reporter, we demonstrated that
this RS domain is necessary and sufficient to target a pro-
tein to the nuclear speckle domains (Table I). These re-
sults demonstrate the existence of two different mecha-
nisms for localization to the speckle domains, based on the
different behavior of two types of RS domains.
The lack of speckle-targeting signals in the RS domain
of human SF2/ASF was unexpected, in light of previous
findings with the RS domains of the Drosophila SWAP
and Tra splicing regulators, which are necessary and suffi-
cient to target reporter proteins to the speckled region (Li
and Bingham, 1991). A recent study further defined the
specific elements within the Tra RS domain required for
localization in the speckled region (Hedley et al., 1995). In
addition to a classical bipartite nuclear localization se-
quence, a novel motif was defined, which is necessary and
sufficient for subnuclear localization. The subnuclear tar-
geting signal of Tra and homologous motifs present in
Drosophila Tra2 and SWAP, and in human U1-70K and
SC35, consist of three or four basic amino acids (generally
arginine and histidine) followed by a run of RS dipeptides
(Hedley et al., 1995). Interestingly, this motif is present in
human SR proteins that have a single RRM (SC35, SRp20
and 9G8) (Ayane et al., 1991; Fu and Maniatis, 1992; Vel-
lard et al., 1992; Cavaloc et al., 1994), but it is absent from
some, though not all, of the SR proteins with two RRMs
(SF2/ASF, SRp40 and SRp30c) (Ge et al., 1991; Krainer et
al., 1991; Screaton et al., 1995).
The Drosophila Tra and SWAP alternative splicing fac-
tors have RS domains, but they lack RRMs. In contrast,
the modular structure of SR proteins, with a COOH-ter-
minal RS domain of variable length and one or two
RRMs, is likely to allow multiple protein–protein and pro-
tein–RNA interactions. The mechanism of nuclear speckle
localization may be a complex process, by analogy to the
pathways described for localization in coiled bodies or in
nucleoli (Schmidt-Zachmann and Nigg, 1993; Bohmann et
al., 1995; Scheer and Weisenberger, 1995), which involve
complex signals rather than simple sequence motifs.
Studies with the Drosophila splicing regulators sug-
gested a mechanism for subnuclear localization based on
protein–protein interactions mediated by the RS domains.
Recent studies pointed to a role for the RS domains of
Drosophila and/or human Tra, Tra2, U2AF35, U1-70K,
and those of several SR proteins in mediating specific pro-
tein–protein interactions, which may be modulated by
phosphorylation of many of the serine residues (Wu and
Maniatis, 1993; Amrein et al., 1994; Kohtz et al., 1994;
Figure 8. Summary of the role of SR protein domains on E1A al-
ternative splicing specificity in vivo. The domain structures of
SF2/ASF and domain-deletion mutants thereof, and that of
SRp20, are shown schematically. The predominant E1A isoform
generated upon overexpression of each protein is shown on the
right. The presence of RRM2 of SF2/ASF correlates with use of
the proximal 13S 59 splice site, whereas proteins that lack this
atypical RRM cause preferential use of the 12S 59 splice site.Cáceres et al. Modularity of SR Proteins: Localization and Splicing 235
Xiao and Manley, 1997). In particular, the RS domains of
SC35 and SF2/ASF are thought to mediate specific inter-
actions with the RS domains of both the U1-70K polypep-
tide and with the 35-kD subunit of the splicing factor
U2AF (Wu and Maniatis, 1993; Kohtz et al., 1994). These
interactions are thought to be involved in defining and
bridging the splice sites during spliceosome assembly, but
in principle they could also play a role in specifying subnu-
clear localization. Although both snRNP polypeptides and
SR proteins colocalize in a speckled distribution, their lo-
calization appears to involve different molecular interac-
tions since the speckled distribution of snRNP proteins is
sensitive to RNase A treatment, while the SC35 distribu-
tion is not affected (Spector et al., 1991).
Proteins that lack RS domains, such as the splicing fac-
tor PSF, are thought to localize to the speckled region by
interacting with snRNPs or with RS domain-containing
proteins (Patton, J., personal communication; Hedley et
al., 1995). Deletion mutants of Tra lacking the RS domain
can still localize in the speckles, provided that they are
able to interact with Tra2 (Hedley et al., 1995). Thus, two
mechanisms may operate to target splicing components to
the nuclear speckles: a direct one, in which the presence of
a targeting signal determines the proper subnuclear local-
ization, and an indirect one, in which proteins lacking a
targeting signal localize to the speckle domains by binding
to splicing components that have a targeting signal. If SF2/
ASF is targeted to the speckles indirectly, by protein–pro-
tein or RNA–protein interactions, the interaction regions
must be redundant since we showed that each of the three
constituent domains can be deleted individually without a
complete loss of localization in the speckle domains. Cur-
rently, the RS domain of SF2/ASF is the only region of the
protein known to be involved in protein–protein interac-
tions, but this domain is neither necessary nor sufficient
for speckle localization of SF2/ASF. Targeting by interac-
tion with RNA is a distinct possibility; to explain the
present localization data, this model would require that a
single RRM derived from an SR protein be unable to in-
teract stably with RNA, and that either a second RRM or
an RS domain be required to stabilize interactions with
RNA. In vitro RNA-binding experiments showed that
these are indeed the properties of SF2/ASF (Cáceres and
Krainer, 1993; Zuo and Manley, 1993; Jamison et al.,
1995). The direct targeting model is more likely for single-
domain SR proteins, such as SC35, whose localization is
RNase resistant (Spector et al., 1991), and which appear to
have short sequence motifs that are sufficient for correct
subnuclear localization (Hedley et al., 1995).
Alternative Splicing Activity of SR Proteins
We analyzed the role of the structural domains of SF2/
Figure 9. Summary of the lo-
calization of SR protein vari-
ants. The domain structures
of the SF2/ASF wild-type
and mutant proteins are
shown schematically above
the line, and those of SRp40,
SC35, and SRp20, with or
without an RS domain, are
shown below the line. The
observed cellular location of
the expressed proteins is in-
dicated as N (nuclear) or C
(cytoplasmic). In all cases,
the expressed proteins were
excluded from nucleoli. Sub-
nuclear accumulation in
speckles is indicated by 1 or
2 signs, with the number of
1 signs reflecting the quanti-
tations shown in Fig. 5. Pro-
teins that did not accumulate
in speckles gave a diffuse nu-
clear pattern.
Table I. Summary of Localization Of Chimeric Proteins
Protein Cellular location Nuclear speckles
A1-RS N 2
NPc C 2
NPc-RSSF2 N 2
NPc-RSSRp20 N 1
The A1-RS protein consists of the two RRMs from hnRNP A1 fused to the COOH-
terminal RS domain of SF2/ASF. NPc is the nucleoplasmin core domain (Dingwall et
al., 1987). This domain was fused to the SF2/ASF RS domain (NPc-RSSF2) or to the
SRp20 RS domain (NPc-RSSRp20). The observed cellular distribution was either nu-
clear (N) or cytoplasmic (C). Subnuclear accumulation in speckles is indicated by 1
or 2 signs.The Journal of Cell Biology, Volume 138, 1997 236
ASF in regulation of alternative splicing in living cells (Fig.
8). We found that the RS domain of SF2/ASF is not re-
quired for regulation of alternative splicing in vivo, since a
mutant protein lacking this domain regulates alternative
splice site selection of an E1A splicing reporter in a man-
ner very similar to the wild type. This finding is consistent
with previous observations made in vitro and in vivo
(Cáceres and Krainer, 1993; Zuo and Manley, 1993; Wang
and Manley, 1995). Whereas the in vitro studies also
showed that the RS domain of SF2/ASF is required for its
full activity in constitutive splicing, the observation that it
is not required for concentration-dependent effects on al-
ternative splicing may suggest that for this particular func-
tion, the lack of the RS domain can be compensated by in-
teractions with other SR proteins. As noted above,
however, the only protein–protein interaction region of
the protein known so far is, in fact, the RS domain (Wu
and Maniatis, 1993; Amrein et al., 1994; Kohtz et al.,
1994).
We showed that the presence of a particular domain,
RRM2 of SF2/ASF, confers selectivity for a specific alter-
native 59 splice site. Thus, all the constructs we analyzed
that included RRM2 favored the most proximal 59 splice
site in E1A pre-mRNA (13S), whereas natural (SRp20) or
mutant (SF2-RRM1/RS) proteins lacking RRM2 selected
the middle 59 splice site (12S). This remarkable difference
in splice site selection demonstrates that the RRMs of
SF2/ASF function as modules that contribute to specificity
in alternative splicing, and that the functions of the two
RRM modules can be separated. Moreover, this effect is
substrate specific since both the mutant SF2/ASF lacking
RRM2 and SRp20 had altered specificity (compared to
the other proteins) with the E1A pre-mRNA but showed
normal specificity with a b-thalassemia pre-mRNA (Screa-
ton et al., 1995; data not shown). We conclude that the se-
lection of alternative splice sites depends on both the
properties of the pre-mRNA as well as on the presence of
particular domains in the SR proteins. However, not all
SR proteins that possess or lack RRM2 will necessarily
have the same alternative splicing specificities as SF2/ASF
and SRp20, respectively. For example, overexpression of
SC35, which has a single RRM, fails to activate 12S splic-
ing (Wang and Manley, 1995; data not shown). These sub-
strate differences among SR proteins are consistent with
the notion that they may function as global regulators of
alternative splicing for distinct classes of pre-mRNAs in
vivo (Screaton et al., 1995).
The mechanistic relation between general or specific
RNA binding by SR proteins and their activity in alterna-
tive splicing regulation has not been established. Although
both RRMs in SF2/ASF are required for efficient binding
to RNA (Cáceres and Krainer, 1993; Zuo and Manley,
1993) and to high affinity sites (Tacke and Manley, 1995),
our present data show that mutants of SF2/ASF lacking ei-
ther RRM1 or RRM2 are nevertheless active in alterna-
tive splicing in vivo. The fact that alternative splicing activ-
ity can be observed in vivo with SF2/ASF mutants lacking
any one of its three constituent domains suggests that this
activity of the protein does not require highly sequence-
specific binding to RNA. On the other hand, the different
splice site activation specificity of the SF2/ASF mutants,
depending on which of the two RRMs was deleted, sug-
gests that sequence-specific interactions may play a role in
selecting particular splice sites for activation. The alterna-
tive splicing activity of SF2/ASF has been shown to corre-
late with its ability to promote multiple occupancy of alter-
native 59 splice sites by U1 snRNP (Eperon et al., 1993).
Interestingly, SF2/ASF mutants lacking either RRM are
still able to form a ternary complex with U1 snRNP and
pre-mRNA containing a functional 59 splice site (Jamison
et al., 1995). The activity of similar mutants in alternative
splicing in vivo is consistent with this finding.
In summary, we have shown that the modular structure
of SR proteins has profound consequences for their cellu-
lar localization, alternative splicing activity, and also their
specificity in alternative 59 splice site selection.
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